Astrana Health Inc (NASDAQ:ASTH) Reports Mixed Q2 2025 Earnings with Revenue Beat but Significant EPS Miss

Astrana Health Inc (NASDAQ:ASTH) reported its second-quarter 2025 earnings, revealing mixed results compared to analyst expectations. The company's performance has triggered notable after-hours trading activity, reflecting investor sentiment toward the earnings miss and broader financial outlook.

Key Financial Results vs. Estimates

• Revenue: The company reported $654.81 million in Q2 2025 revenue, slightly above the consensus estimate of $651.09 million. This represents a modest beat of approximately 0.6%.
• Earnings Per Share (EPS): Astrana posted an EPS of $0.19, significantly below the estimated $0.37. This miss of nearly 49% has weighed on investor confidence.

Market Reaction

Following the earnings release, Astrana’s stock surged 10.39% in after-hours trading, an unexpected move given the substantial EPS shortfall. This suggests that investors may be focusing on the revenue beat or potential forward-looking optimism not fully captured in the immediate numbers. However, the stock has struggled in recent weeks, declining 10.06% over the past month, indicating broader concerns prior to the earnings announcement.

Analyst Estimates for Future Performance

Looking ahead, analysts project:

• Q3 2025 Revenue: $897.56 million (estimate)
• Full-Year 2025 Revenue: $2.974 billion (estimate)
• Full-Year 2025 EPS: $1.22 (estimate)

The company did not provide explicit guidance in its press release, leaving investors to rely on external estimates. The lack of forward-looking commentary from management could contribute to uncertainty, though the after-hours rally suggests some traders see value at current levels.

Press Release Summary

Astrana Health announced its Q2 2025 results, emphasizing its role as a provider-centric, technology-driven healthcare company. The press release highlighted consolidated financial performance but did not delve into specific operational updates or strategic initiatives. A conference call scheduled for August 7, 2025, at 2:30 p.m. PT may provide further clarity.

For a deeper dive into Astrana Health’s earnings history and future estimates, review the full earnings and estimates breakdown here.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before making any decisions.